Summit Therapeutics Total Long-Term Assets 2015-2024 | SMMT

Summit Therapeutics total long-term assets for the quarter ending September 30, 2024 were $0.013B, a 7.12% decline year-over-year.

  • Summit Therapeutics total long-term assets for 2023 were $0.013B, a 77.53% increase from 2022.
  • Summit Therapeutics total long-term assets for 2022 were $0.007B, a 53.58% decline from 2021.
  • Summit Therapeutics total long-term assets for 2021 were $0.016B, a 8.35% increase from 2020.

Summit Therapeutics Total Long-Term Assets 2015-2024 | SMMT

  • Summit Therapeutics total long-term assets for 2023 were $0.013B, a 77.53% increase from 2022.
  • Summit Therapeutics total long-term assets for 2022 were $0.007B, a 53.58% decline from 2021.
  • Summit Therapeutics total long-term assets for 2021 were $0.016B, a 8.35% increase from 2020.